Rhythm Pharmaceuticals Inc (NAS:RYTM)
$ 67.33 3.43 (5.37%) Market Cap: 4.14 Bil Enterprise Value: 3.63 Bil PE Ratio: 0 PB Ratio: 349.18 GF Score: 60/100

Rhythm Pharmaceuticals Inc Annual Shareholders Meeting Transcript

Jun 17, 2020 / 06:00PM GMT
Release Date Price: $21.37 (+2.59%)
Operator

Good afternoon. Hello, and welcome to the Annual Meeting of Stockholders of Rhythm Pharmaceuticals, Inc. Please note that today's meeting is being recorded.

(Operator Instructions)

It is now my pleasure to turn today's meeting over to David Meeker, Chairman of the Rhythm Board of Directors.

David P. Meeker
Rhythm Pharmaceuticals, Inc. - Independent Chairman of the Board

Good afternoon. I am David Meeker, Chairman of the Board of Directors of Rhythm Pharmaceuticals and Chairperson of today's meeting. Let me take this opportunity to welcome all those attending our 2020 annual meeting of stockholders which we are holding virtually in light of the COVID-19 pandemic.

Before the meeting is called to order, I'd like to introduce to you the other members of the Board and officers of the company who are on the webcast today. From the Board are: Stuart Arbuckle; Todd Foley; Jennifer Good; Christophe Jean; Ed Mathers; and David McGirr. From the company, we also have Hunter Smith, our Interim President and Chief Executive Officer and Chief

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot